文献速递心血管MRUSPET

多模态影像刻画不同类型淀粉样变性的心脏表型

Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis.
PubMed 文献 · JACC Cardiovasc Imaging · 2022-09-14

本研究纳入296例系统性淀粉样变性患者,采用生物标志物、超声心动图和心脏磁共振(CMR)全面刻画心脏表型,并按骨闪烁显像心肌摄取程度分级。结果显示不同淀粉样变类型在不同摄取分级下的心脏表型差异显著,CMR联合骨闪烁显像有助于鉴别诊断和临床表型定义。

要点

  • AL型心肌摄取0级者CMR表现可从无心脏受累到典型心脏淀粉样变性(CA)。
  • AL型1级患者100%具有典型CA,而ATTR型1级仅Ser77Tyr突变者11.4%有典型CA。
  • 排除Ser77Tyr、AApoAI和AApoAIV后,0-1级摄取者CMR典型CA或ECV>0.40对AL诊断敏感度和特异度均为100%。

核心结论

  • 不同淀粉样变类型在不同心肌摄取程度下心脏表型差异广泛,CMR联合骨闪烁显像可帮助确定诊断鉴别和个体临床表型。

研究设计与样本

  • 单中心研究纳入296例系统性淀粉样变性患者(AL 117例,ATTR 165例,AApoAI 7例,AApoAIV 7例),行生物标志物、超声心动图和CMR深度表型分析,并按骨闪烁显像心肌摄取分级(0-3级)分组。

关键影像表现/征象

  • AL型0级摄取者CMR表现谱从无CA到典型CA,而1-3级者均呈典型CMR特征。
  • ATTR型中心肌示踪剂摄取与CA负荷强相关,但Ser77Tyr突变者例外。
  • AApoAI型表现为0或1级摄取,伴不成比例的右侧受累。
  • AApoAIV型均为0级摄取,但呈典型CA。

诊断标准与关键数值

  • AL型1级患者(n=48)100%有典型CA;ATTR型1级中仅Ser77Tyr突变者(n=5,11.4%)有典型CA。
  • 排除Ser77Tyr、AApoAI和AApoAIV后,0-1级心肌摄取者CMR显示典型CA或细胞外容积(ECV)>0.40对AL诊断的敏感度和特异度均为100%。

临床应用与阅片要点

  • 对怀疑心脏淀粉样变性者,应结合骨闪烁显像心肌摄取分级与CMR特征综合判断,注意AL型0级摄取者仍可能存在典型CA。
  • ATTR型1级摄取者若为Ser77Tyr突变,CMR可显示典型CA,需与其他类型鉴别。
  • AApoAI型可表现为0-1级摄取伴右心受累为主,AApoAIV型为0级摄取但CMR呈典型CA,阅片时需警惕。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Bone scintigraphy is extremely valuable when assessing patients with suspected cardiac amyloidosis (CA), but the clinical significance and associated phenotype of different degrees of cardiac uptake across different types is yet to be defined.

OBJECTIVES: This study sought to define the phenotypes of patients with varying degrees of cardiac uptake on bone scintigraphy, across multiple types of systemic amyloidosis, using extensive characterization comprising biomarkers as well as echocardiographic and cardiac magnetic resonance (CMR) imaging.

METHODS: A total of 296 patients (117 with immunoglobulin light-chain amyloidosis [AL], 165 with transthyretin amyloidosis [ATTR], 7 with apolipoprotein AI amyloidosis [AApoAI], and 7 with apolipoprotein AIV amyloidosis [AApoAIV]) underwent deep characterization of their cardiac phenotype.

RESULTS: AL patients with grade 0 myocardial radiotracer uptake spanned the spectrum of CMR findings from no CA to characteristic CA, whereas AL patients with grades 1 to 3 always produced characteristic CMR features. In ATTR, the CA burden strongly correlated with myocardial tracer uptake, except in Ser77Tyr. AApoAI presented with grade 0 or 1 and disproportionate right-sided involvement. AApoAIV always presented with grade 0 and characteristic CA. AL grade 1 patients (n = 48; 100%) had characteristic CA, whereas only ATTR grade 1 patients with Ser77Tyr had characteristic CA on CMR (n = 5; 11.4%). After exclusion of Ser77Tyr, AApoAI, and AApoAIV, CMR showing characteristic CA or an extracellular volume of >0.40 in patients with grade 0 to 1 cardiac uptake had a sensitivity and specificity of 100% for AL.

CONCLUSIONS: There is a wide variation in cardiac phenotype between different amyloidosis types across different degrees of cardiac uptake. The combination of CMR and bone scintigraphy can help to define the diagnostic differentials and the clinical phenotype in each individual patient.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Ioannou, Patel, Razvi, et al. Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis. JACC Cardiovasc Imaging. 2022. PMID: 36648052. doi:10.1016/j.jcmg.2022.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。